Advertisement
Screener

TRACON Pharmaceuticals, Inc. Patents: Applications Pending

TRACON Pharmaceuticals, Inc. Patent Applications Pending

13 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2018-03-29: Application PCTUS2018025207; Invention COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-PROGRAMMED DEATH RECEPTOR AGENTS; Applicant TRACON PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
  • 2017-10-05: Application PCTUS2017055345; Invention COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS; Applicant TRACON PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
  • 2017-04-07: Application 62483054; Invention COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-PROGRAMMED DEATH RECEPTOR AGENTS; Applicant Tracon Pharmaceuticals, Inc.; Status Provisional Application Expired.
  • 2016-10-06: Application 62405059; Invention COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS; Applicant Tracon Pharmaceuticals, Inc.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2018-03-29PCTUS2018025207COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-PROGRAMMED DEATH RECEPTOR AGENTSTRACON PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
LUKAS HAWINKELS
CHARLES THEUER
Netherlands
United States
THOMAS, SHANE M
2017-10-05PCTUS2017055345COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERSTRACON PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
CHARLES THEUER
United States
THOMAS, SHANE M
2017-04-0762483054COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-PROGRAMMED DEATH RECEPTOR AGENTSTracon Pharmaceuticals, Inc.Provisional Application Expired
Charles Theuer
Lukas Hawinkels
United States
Netherlands
2016-10-0662405059COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERSTracon Pharmaceuticals, Inc.Provisional Application Expired
Charles Theuer
United States
2015-11-11PCTUS2015060136ANTI-ENDOGLIN ANTIBODIES AND USES THEREOFTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
CHARLES THEUER
United States
2015-05-1462161669ANTI-ENDOGLIN ANTIBODIES AND USES THEREOFTracon Pharmaceuticals, Inc.Provisional Application Expired
Charles Theuer
United States
2014-11-1262078788ANTI-ENDOGLIN ANTIBODIES AND USES THEREOFTracon Pharmaceuticals, Inc.Provisional Application Expired
Charles Theuer
United States
2013-09-05PCTUS2013058265ANTIBODY FORMULATIONS AND USES THEREOFTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SUZANNE BENEDICT
MARK CORNELL MANNING
BRIAN M. MURPHY
SHARON REAL
CHARLES THEUER
United States
United States
United States
United States
United States
2011-04-15PCTUS2011032762POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORSTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
CHARLES THEUER
United States
YOUNG, LEE W
2010-09-29PCTUS2010050759ENDOGLIN ANTIBODIESTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MAXIMILIANO VASQUEZ
CHARLES THEUER
United States
United States
YOUNG, LEE W
2010-08-16PCTUS2010045651COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTSTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
BEN K. SEON
CHARLES P. THEUER
United States
United States
YOUNG, LEE W
2009-09-30PCTUS2009059086HUMANIZED ENDOGLIN ANTIBODIESTRACON PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MAXIMILIANO VASQUEZ
CHARLES THEUER
United States
United States
2007-12-21PCTUS2007088666ANTIFOLATE AGENT COMBINATIONS IN THE TREATMENT OF CANCERTRACON PHARMACEUTICALS,INCPCT - IPER (International Preliminary Examination Report) 409-416 Mailed
CHARLES P. THEUER
BONNE JEAN ADAMS
United States
United States
ANDERSON, JAMES D